As of Jul 29
| -0.41 / -13.53%|
The 7 analysts offering 12-month price forecasts for Evoke Pharma Inc have a median target of 9.00, with a high estimate of 22.00 and a low estimate of 0.20. The median estimate represents a +243.51% increase from the last price of 2.62.
The current consensus among 7 polled investment analysts is to Hold stock in Evoke Pharma Inc. This rating has held steady since July, when it was downgraded from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.